Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe new data on strategies to reduce drug resistance associated with antiretroviral therapy for prevention of mother-to-child HIV transmission
- Discuss recent findings on the impact of minority variants on virologic response to NNRTI-based regimens
- Summarize new data on novel approaches to evaluate viral tropism
- Cite recent insights into resistance from studies of maraviroc, darunavir/ritonavir, lopinavir/ritonavir, and etravirine